Membership

Newsletters

April 2014 Newsletter

Spotlight on KRAS Mutant Lung Cancer
Werner H. Kirsten was a young pathologist working at the University of Chicago. He noted with interest that he could transmit leukemia to rats with cell free extract obtained from leukemic mice, which suggested the presence of a microscopic transmitting agent such as a virus.

March 2014 Newsletter

Spotlight on BRAF-Mutant Lung Cancers
President's Corner: The Audi A3 Diesel and Volkswagen Golf Diesel are different cars. They look different, drive differently and are priced differently. However, the fact is that both cars use the exact same TDI (Turbocharged Direct Injection) engine. Should we consider them to be the same or different cars?

February 2014 Newsletter

“Om” is the most sacred syllable in Sanskrit language that reflects wisdom. “Oops” is the stupid sound we make when we have said or done something wrong. Over the past ten years of clinical research on molecular targeted therapy we have experienced much “Om” and “Oops”.

January 2014 Newsletter

Early detection saves lives. This statement is well established for multiple malignancies including breast, liver, colorectal and cervical cancers. But for lung cancer, supporting evidence for early detection of lung cancer has been lacking until the release of National Lung Screening Trial (NLST) data in 2011.

December 2013 Newsletter

I would like to take this unique opportunity to wish all members of IASLC a prosperous 2014. According to the Chinese Lunar Calendar (New Year starts on January 31), 2014 is Year of the Horse, which represents energy, warmth, intelligence and durability. The Chinese word “Qianli Ma” literally means “thousand mile horse” implying someone with ability to endure hardship and to complete the designated mission.

November 2013

IASLC was built on friendship and will only grow by the support of friendship. Over the next few years we shall take our friendship to a new horizon. The strength of our current membership is broad representation of specialists with targeted interest in prevention, diagnosis, treatment and research in lung cancer. However, we actually have a few members from community oncology practice who deliver direct care to a large portion of lung cancer patients. They look after multiple cancer types, thus will demand more precise and practical information.

Pages